PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
25.60%
Positive revenue growth while 6203.T is negative. John Neff might see a notable competitive edge here.
-7.70%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-24.53%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-24.68%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-20.81%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-20.79%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-20.79%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.00%
Share reduction while 6203.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 6203.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
123.88%
Positive 10Y revenue/share CAGR while 6203.T is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
52.47%
5Y revenue/share CAGR 1.25-1.5x 6203.T's 38.05%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
24.56%
3Y revenue/share CAGR similar to 6203.T's 24.25%. Walter Schloss would assume both companies experience comparable short-term cycles.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
790.14%
Net income/share CAGR above 1.5x 6203.T's 164.52% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
42.26%
Below 50% of 6203.T's 177.78%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
69.31%
3Y net income/share CAGR above 1.5x 6203.T's 14.07%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
140.71%
10Y equity/share CAGR above 1.5x 6203.T's 18.16%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
58.54%
5Y equity/share CAGR above 1.5x 6203.T's 24.25%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
35.59%
3Y equity/share CAGR above 1.5x 6203.T's 14.59%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
31.29%
Our AR growth while 6203.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
4.50%
We show growth while 6203.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
13.87%
Asset growth above 1.5x 6203.T's 0.33%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.69%
50-75% of 6203.T's 5.32%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
26.34%
We have some new debt while 6203.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
4.83%
SG&A growth well above 6203.T's 3.28%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.